PREDICTION OF POSTPARTUM HELLP SYNDROME, POSTPARTUM ECLAMPSIA OR POSTPARTUM PREECLAMPSIA

    公开(公告)号:US20200378981A1

    公开(公告)日:2020-12-03

    申请号:US16998444

    申请日:2020-08-20

    IPC分类号: G01N33/68

    摘要: The present invention is directed to a method for predicting the risk of a female subject to develop postpartum HELLP syndrome, postpartum preeclampsia, or postpartum eclampsia. The method is based on the determination of the levels of i) sFlt-1 and PlGF, or ii) Endoglin and PlGF in a first sample obtained from said subject before delivery of baby, and a second sample of from said subject obtained after delivery of baby. Moreover, encompassed by the invention are devices and kits for carrying out the method of the present invention.

    PREDICTION OF POSTPARTUM HELLP SYNDROME, POSTPARTUM ECLAMPSIA OR POSTPARTUM PREECLAMPSIA
    3.
    发明申请
    PREDICTION OF POSTPARTUM HELLP SYNDROME, POSTPARTUM ECLAMPSIA OR POSTPARTUM PREECLAMPSIA 审中-公开
    前列腺癌综合征,前列腺癌或前列腺癌的预测

    公开(公告)号:US20160327564A1

    公开(公告)日:2016-11-10

    申请号:US15216980

    申请日:2016-07-22

    IPC分类号: G01N33/68

    摘要: The present invention is directed to a method for predicting the risk of a female subject to develop postpartum HELLP syndrome, postpartum preeclampsia, or postpartum eclampsia. The method is based on the determination of the levels of i) sFlt-1 and PlGF, or ii) Endoglin and PlGF in a first sample obtained from said subject before delivery of baby, and a second sample of from said subject obtained after delivery of baby. Moreover, encompassed by the invention are devices and kits for carrying out the method of the present invention.

    摘要翻译: 本发明涉及一种预测女性受试者产生产后HELLP综合征,产后先兆子痫或产后子痫风险的方法。 该方法是基于i)sFlt-1和PlGF的水平的确定,或ii)在分娩前从所述受试者获得的第一样品中的内皮糖蛋白和PlGF,以及在分娩后获得的来自所述受试者的第二个样品 宝宝。 此外,本发明包括用于实施本发明的方法的装置和套件。